CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Glimepiride

格列美脲 杂质对照品Glimepiride Impurities

EP44 个杂质条目44 impurity entries

本页汇总 格列美脲 的 44 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 44 impurity reference standards of Glimepiride with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 格列美脲(Glimepiride)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesAnalytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry
    Journal of pharmaceutical sciences · 2023 · Solanki R et al.  ·  PMID 36822274  ·  DOI
  2. 杂质研究Impurity studiesSimultaneous Determination of Metformin, Glipizide, Repaglinide, and Glimepiride or Metformin and Pioglitazone by a Validated LC Method: Application in the Presence of Metformin Impurity (1-Cyanoguanidine)
    Journal of AOAC International · 2016 · El-Zaher AA et al.  ·  PMID 27214744  ·  DOI
  3. 杂质研究Impurity studiesStability Indicating RP-HPLC Method for the Simultaneous Determination of Atorvastatin Calcium, Metformin Hydrochloride, and Glimepiride in Bulk and Combined Tablet Dosage Form
    International scholarly research notices · 2014 · Ramesh D, Habibuddin M  ·  PMID 27433531  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma
    Chemistry Central journal · 2012 · El-Enany NM et al.  ·  PMID 22277722  ·  DOI
  5. 分析方法Analytical MethodsSpectrophotometric methods for determination of glimepiride and pioglitazone hydrochloride mixture and application in their pharmaceutical formulation
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2022 · Ghoniem NS et al.  ·  PMID 34972054  ·  DOI

格列美脲 —— 原料药与杂质对照品Glimepiride — drug substance & impurities

共 45 个条目(含原料药本体)45 items incl. the drug substance
Glimepiride structure
EP原料药 APIAPI
格列美脲Glimepiride
Glimepiride
CAS No.93479-97-1
Chemical FormulaC24H34N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 1 (Glimepiride EP Impurity A) structure
EPA
格列美脲杂质1 (格列美脲EP杂质A)Glimepiride Impurity 1 (Glimepiride EP Impurity A)
Glimepiride Impurity 1 (Glimepiride EP Impurity A)
CAS No.684286-46-2
Chemical FormulaC24H34N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 2 (Glimepiride EP Impurity B) structure
EPB
格列美脲杂质2 (格列美脲EP杂质B)Glimepiride Impurity 2 (Glimepiride EP Impurity B)
Glimepiride Impurity 2 (Glimepiride EP Impurity B)
CAS No.119018-29-0
Chemical FormulaC16H21N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 3 (Glimepiride EP Impurity C) structure
EPC
格列美脲杂质3 (格列美脲EP杂质C)Glimepiride Impurity 3 (Glimepiride EP Impurity C)
Glimepiride Impurity 3 (Glimepiride EP Impurity C)
CAS No.119018-30-3
Chemical FormulaC18H23N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 4 (Glimepiride EP Impurity D) structure
EPD
格列美脲杂质4 (格列美脲EP杂质D)Glimepiride Impurity 4 (Glimepiride EP Impurity D)
Glimepiride Impurity 4 (Glimepiride EP Impurity D)
CAS No.791104-62-6
Chemical FormulaC24H34N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 5 (Glimepiride EP Impurity E) structure
EPE
格列美脲杂质5 (格列美脲EP杂质E)Glimepiride Impurity 5 (Glimepiride EP Impurity E)
Glimepiride Impurity 5 (Glimepiride EP Impurity E)
CAS No.2366968-77-4
Chemical FormulaC16H21N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 6 (Glimepiride EP Impurity F) structure
EPF
格列美脲杂质6 (格列美脲EP杂质F)Glimepiride Impurity 6 (Glimepiride EP Impurity F)
Glimepiride Impurity 6 (Glimepiride EP Impurity F)
CAS No.2731586-74-4
Chemical FormulaC18H23N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 8 (Glimepiride EP Impurity H) structure
EPH
格列美脲杂质8 (格列美脲EP杂质H)Glimepiride Impurity 8 (Glimepiride EP Impurity H)
Glimepiride Impurity 8 (Glimepiride EP Impurity H)
CAS No.2724503-28-8
Chemical FormulaC24H28N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 9 (Glimepiride EP Impurity I) structure
EPI
格列美脲杂质9 (格列美脲EP杂质I)Glimepiride Impurity 9 (Glimepiride EP Impurity I)
Glimepiride Impurity 9 (Glimepiride EP Impurity I)
CAS No.878480-70-7
Chemical FormulaC24H34N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 10 (Glimepiride EP Impurity J) structure
EPJ
格列美脲杂质10 (格列美脲EP杂质J)Glimepiride Impurity 10 (Glimepiride EP Impurity J)
Glimepiride Impurity 10 (Glimepiride EP Impurity J)
CAS No.41176-98-1
Chemical FormulaC16H25N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 7 structure
7
格列美脲杂质7Glimepiride Impurity 7
Glimepiride Impurity 7
CAS No.2725395-40-2
Chemical FormulaC19H25N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 12 structure
12
格列美脲杂质12Glimepiride Impurity 12
Glimepiride Impurity 12
CAS No.247098-18-6
Chemical FormulaC16H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 19 structure
19
格列美脲杂质19Glimepiride Impurity 19
Glimepiride Impurity 19
CAS No.32175-01-2
Chemical FormulaC8H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 21 structure
21
格列美脲杂质21Glimepiride Impurity 21
Glimepiride Impurity 21
CAS No.32175-00-1
Chemical FormulaC8H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 24 structure
24
格列美脲杂质24Glimepiride Impurity 24
Glimepiride Impurity 24
CAS No.2523-55-9
Chemical FormulaC7H15N
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 25 structure
25
格列美脲杂质25Glimepiride Impurity 25
Glimepiride Impurity 25
CAS No.73631-58-0
Chemical FormulaC8H11NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 26 structure
26
格列美脲杂质26Glimepiride Impurity 26
Glimepiride Impurity 26
CAS No.35303-76-5
Chemical FormulaC8H12N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 29 structure
29
格列美脲杂质29Glimepiride Impurity 29
Glimepiride Impurity 29
CAS No.546-74-7
Chemical FormulaC2H5NaO4S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 31 Sodium Salt structure
31
格列美脲杂质31 钠盐Glimepiride Impurity 31 Sodium Salt
Glimepiride Impurity 31 Sodium Salt
CAS No.512-42-5
Chemical FormulaCH3O4S-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 31 Potassium Salt structure
31
格列美脲杂质31 钾盐Glimepiride Impurity 31 Potassium Salt
Glimepiride Impurity 31 Potassium Salt
CAS No.562-54-9
Chemical FormulaCH3O4S-·K+
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 31 structure
31
格列美脲杂质31Glimepiride Impurity 31
Glimepiride Impurity 31
CAS No.75-93-4
Chemical FormulaCH4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 33 structure
33
格列美脲杂质33Glimepiride Impurity 33
Glimepiride Impurity 33
CAS No.600177-94-4
Chemical FormulaC24H34N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 35 structure
35
格列美脲杂质35Glimepiride Impurity 35
Glimepiride Impurity 35
CAS No.81760-42-1
Chemical FormulaC8H12N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 36 structure
36
格列美脲杂质36Glimepiride Impurity 36
Glimepiride Impurity 36
CAS No.933705-21-6
Chemical FormulaC8H12N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 37 structure
37
格列美脲杂质37Glimepiride Impurity 37
Glimepiride Impurity 37
CAS No.41176-69-6
Chemical FormulaC15H28N2O
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 38 structure
38
格列美脲杂质38Glimepiride Impurity 38
Glimepiride Impurity 38
CAS No.318515-70-7
Chemical FormulaC19H25N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 39 Hydrochloride structure
39
格列美脲杂质39 盐酸盐Glimepiride Impurity 39 Hydrochloride
Glimepiride Impurity 39 Hydrochloride
CAS No.156-28-5
Chemical FormulaC8H11N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 40 structure
40
格列美脲杂质40Glimepiride Impurity 40
Glimepiride Impurity 40
CAS No.5467-84-5
Chemical FormulaC17H20N2O
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 41 structure
41
格列美脲杂质41Glimepiride Impurity 41
Glimepiride Impurity 41
CAS No.6321-23-9
Chemical FormulaC7H15N
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 42 structure
42
格列美脲杂质42Glimepiride Impurity 42
Glimepiride Impurity 42
CAS No.15507-13-8
Chemical FormulaC4H10O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 43 structure
43
格列美脲杂质43Glimepiride Impurity 43
Glimepiride Impurity 43
CAS No.607-97-6
Chemical FormulaC8H14O3
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 44 structure
44
格列美脲杂质44Glimepiride Impurity 44
Glimepiride Impurity 44
CAS No.247098-17-5
Chemical FormulaC9H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 45 structure
45
格列美脲杂质45Glimepiride Impurity 45
Glimepiride Impurity 45
CAS No.61892-80-6
Chemical FormulaC9H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 46 structure
46
格列美脲杂质46Glimepiride Impurity 46
Glimepiride Impurity 46
CAS No.766-36-9
Chemical FormulaC7H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 47 structure
47
格列美脲杂质47Glimepiride Impurity 47
Glimepiride Impurity 47
CAS No.119043-16-2
Chemical FormulaC16H19ClN2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 48 structure
48
格列美脲杂质48Glimepiride Impurity 48
Glimepiride Impurity 48
CAS No.6914-92-7
Chemical FormulaC2H6O5S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 49 structure
49
格列美脲杂质49Glimepiride Impurity 49
Glimepiride Impurity 49
CAS No.138428-37-2
Chemical FormulaC8H11NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 50 structure
50
格列美脲杂质50Glimepiride Impurity 50
Glimepiride Impurity 50
CAS No.6850-63-1
Chemical FormulaC8H17N
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 51 structure
51
格列美脲杂质51Glimepiride Impurity 51
Glimepiride Impurity 51
CAS No.2775363-46-5
Chemical FormulaC6H7NO4
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 52 structure
52
格列美脲杂质52Glimepiride Impurity 52
Glimepiride Impurity 52
CAS No.4710-17-2
Chemical FormulaC8H12N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 54 structure
54
格列美脲杂质54Glimepiride Impurity 54
Glimepiride Impurity 54
CAS No.1094938-11-0
Chemical FormulaC8H12N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Glimepiride Impurity 56 structure
56
格列美脲杂质56Glimepiride Impurity 56
Glimepiride Impurity 56
CAS No.500230-18-2
Chemical FormulaC2H4Cl2O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Lacosamide Impurity C59 structure
C59
拉考沙胺杂质C59Lacosamide Impurity C59
Lacosamide Impurity C59
CAS No.1466-67-7
Chemical FormulaC15H16N2O
Purity>95%现货In stock
10mg25mg50mg100mg
Glimepiride Impurity 32-d6 structure
32-D6
格列美脲杂质32-d6Glimepiride Impurity 32-d6
Glimepiride Impurity 32-d6
CAS No.15199-43-6
Chemical FormulaC2D6O4S
Purity>95%询价On request
Glimepiride Impurity 30-d10 structure
30-D10
格列美脲杂质30-d10Glimepiride Impurity 30-d10
Glimepiride Impurity 30-d10
CAS No.96617-81-1
Chemical FormulaC4D10O4S
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

格列美脲 —— 研究文献与合成路线Glimepiride — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 格列美脲 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Glimepiride. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability Indicating RP-HPLC Method for the Simultaneous Determination of Atorvastatin Calcium, Metformin Hydrochloride, and Glimepiride in Bulk and Combined Tablet Dosage Form
    Ramesh D, Habibuddin M · International scholarly research notices · 2014 · 被引 7cited 7
  2. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride
    Bansal G, Singh M, Jindal KC, et al. · Journal of pharmaceutical and biomedical analysis · 2008 · 被引 23cited 23
  3. LC determination of glimepiride and its related impurities
    Khan MA, Sinha S, Vartak S, et al. · Journal of pharmaceutical and biomedical analysis · 2005 · 被引 13cited 13
  4. Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry
    Solanki R, Wadhwana P, Patel R, et al. · Journal of pharmaceutical sciences · 2023 · 被引 6cited 6
  5. Simultaneous Determination of Metformin, Glipizide, Repaglinide, and Glimepiride or Metformin and Pioglitazone by a Validated LC Method: Application in the Presence of Metformin Impurity (1-Cyanoguanidine)
    El-Zaher AA, Elkady EF, Elwy HM, et al. · Journal of AOAC International · 2016 · 被引 8cited 8
  6. Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride, and glimepiride by RP-HPLC in tablet formulation
    Jain D, Jain S, Jain D, et al. · Journal of chromatographic science · 2008 · 被引 27cited 27

合成与制备工艺专利Synthesis & process patents

  1. Preparation method for Glimepiride bulk drug
    ZHIGANG NIU, JIAFENG YE, SHULING YU · 公开号 CN101671290CN101671290 · 2010
  2. Preparation of glimepiride raw material
    XIAOCHENG LI, DESHUI QIAO, XUEQIN GAO · 公开号 CN101486674CN101486674 · 2009
  3. A NOVEL PROCESS FOR PREPARATION OF SUBSTANTIALLY PURE GLIMEPIRIDE
    TARUR VENKATASUBRAMANIAN RADHA, KADAM SURESH MAHADEV, NAIK SANJAY JANARDHAN, GAVHANE SACHIN BABAN · 公开号 KR20070116778KR20070116778 · 2007
  4. A NOVEL PROCESS FOR PREPARATION OF SUBSTANTIALLY PURE GLIMEPIRIDE
    NAIK SANJAY JANARDHAN, GAVHANE SACHIN BABAN, TARUR VENKATASUBRAMANIAN RADHA, KADAM SURESH MAHADEV · 公开号 CA2582230CA2582230 · 2006
  5. A novel process for preparation of substantially pure Glimepiride
    GAVHANE SACHIN BABAN, TARUR VENKATASUBRAMANIAN RADHA, NAIK SANJAY JANARDHAN, KADAM SURESH MAHADEV · 公开号 AU2005329763AU2005329763 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

格列美脲 杂质谱研究要点Glimepiride — impurity profiling notes

下面这些是拿到 格列美脲 的 45 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 45 impurity entries for Glimepiride, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances